MeImmS: Predict Clinical Benefit of Anti-PD-1/PD-L1 Treatments Based on DNA Methylation in Non-small Cell Lung Cancer

Immunotherapy has become an effective therapy for cancer treatment. However, the development of biomarkers to predict immunotherapy response still remains a challenge. We have developed the DNA Methylation Immune Score, named “MeImmS,” which can predict clinical benefits of non-small cell lung cance...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Shipeng, Li, Xin, Gao, Yue, Guo, Shuang, Sun, Dailin, Zhou, Hanxiao, Sun, Yue, Wang, Peng, Zhi, Hui, Bai, Jing, Ning, Shangwei, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173132/
https://www.ncbi.nlm.nih.gov/pubmed/34093667
http://dx.doi.org/10.3389/fgene.2021.676449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173132/
https://www.ncbi.nlm.nih.gov/pubmed/34093667
http://dx.doi.org/10.3389/fgene.2021.676449

Ejemplares similares